Shree Ganesh Remedies informs about statement of utilization of proceeds of rights issue

05 Feb 2025 Evaluate
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, Shree Ganesh Remedies has informed that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Rights Issue of the Company during the quarter and nine months ended December 31, 2024, as mentioned in the letter of offer. It has enclosed a statement in this regard. The aforesaid statement has been reviewed by the Audit Committee and taken on record by the Board at their respective meetings held on February 05, 2024. It is further been informed that the company has fully utilized all the proceeds of the Rights Issue during the quarter and nine months ended December 31, 2024, hence no further statements of utilization/deviation will be submitted from next quarter onwards.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

710.25 12.05 (1.73%)
28-Mar-2025 10:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...